Viewing Study NCT06067568


Ignite Creation Date: 2025-12-24 @ 5:37 PM
Ignite Modification Date: 2025-12-29 @ 1:17 PM
Study NCT ID: NCT06067568
Status: COMPLETED
Last Update Posted: 2024-03-15
First Post: 2023-09-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese Participants
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module